BridgeBio Pharma Inc
BBIO
Market Cap$9.89B
Close$
$-9.00
117.4% downside
Current Fair Value
117.4% downsideOvervalued by 117.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $9.89 Billion |
|---|---|
| Enterprise Value | $11.83 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.88 |
| Beta | 1.23 |
| Outstanding Shares | 190,517,215 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -12.7 |
|---|---|
| PEG | -8.6 |
| Price to Sales | 51.84 |
| Price to Book Ratio | -5.18 |
| Enterprise Value to Revenue | 50.18 |
| Enterprise Value to EBIT | -18.4 |
| Enterprise Value to Net Income | -16 |
| Total Debt to Enterprise | 0.23 |
| Debt to Equity | -1.5 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About BridgeBio Pharma Inc
CEO: Neil Kumar